TABLE 3.
Monosaccharides composition, molecular weight, structures, and bioactivities of polysaccharides purified from S. nigrum.
No. | Polysaccharides | Monosaccharide composition | M.W. (Da) | Structures | Bioactivities | References |
---|---|---|---|---|---|---|
1 | S1 | mannose, glucose, galactose, arabinose in a ratio of 1.00: 8.32: 6.72: 2.90 | 5.44 × 104 | ND | Prebiotic effects | Yao et al. (2020) |
2 | S2 | rhamnose, galacturonic acid, glucose, galactose, arabinose in a ratio of 1.00: 0.76: 4.57: 7.25: 4.49 | 7.22 × 104 | ND | Prebiotic effects | Yao et al. (2020) |
3 | SNL-1 | rhamnose, xylose, arabinose, glucose in a ratio of 4.9: 1: 2. 4: 13 | 5.30 × 103 | α-glycosidic and β- glycosidic linkages | ND | Xiao and Zeng (1998) |
4 | SNL-2 | glucose, arabinose in a ratio of 13.3: 1 | 1.12 × 104 | α-glycosidic and β- glycosidic linkages | ND | Xiao and Zeng (1998) |
5 | SNL-3 | xylose, mannose, glucose, galactose in a ratio of 75.7: 9.2: 4.9: 10.2 | 2.37 × 104 | 1, 3 xyl residue linkage | Immunomodulatory activity | Xiao and Zeng (2000) |
6 | SNL-4 | xylose, mannose galactose in a ratio of 89.4: 1.7: 8.9 | 4.77 × 104 | 1, 3 xyl residue linkage | Immunomodulatory activity | Xiao and Zeng (2000) |
7 | SNL-WP-1 | galactose, glucose, mannose, arabinose in a ratio of 1.8: 1: 1.2: 2 | 1.41 × 104 | β-glycosidic linkages | Antitumor activity | Li (2010a) |
8 | SNL-WP-2 | galactose, glucose, mannose, xylose, arabinose in a ratio of 5.4:10.4: 1.4: 1: 1.6 | 9.12 × 103 | ND | Antitumor activity | Li (2010a) |
9 | SNL-AP-1 | galactose, glucose, mannose, xylose, arabinose in a ratio of 28: 1: 6: 51: 13 | >1.6× 106 | β-glycosidic linkages | Antitumor activity | Li (2010a) |
10 | SNL-AP-2 | galactose, glucose, mannose, xylose, arabinose in a ratio of 5.8: 1: 1.3: 2.6: 2 | >1.6× 106 | β-glycosidic linkages | Antitumor activity | Li (2010a) |
11 | SNLBP | xylose, mannose, glucose, galactose in a ratio of 82.2: 7.4: 3.8: 6.6 | ND | β-glycosidic linkages | Immunomodulatory activity | Liu (2003) |
12 | SNL-P1a | rhamnose, xylose, arabinose, glucose | ND | β (1→3) glycosidic bond | Immunomodulatory and antitumor activity | Li (2009) |